OverviewSuggest Edit

Bausch Health (also known as Bausch Health Companies, formerly known as Valeant Pharmaceuticals) is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. It operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers vision care, surgical, consumer, and ophthalmology Rx products; Solta products, branded and generic pharmaceutical products, OTC products, medical devices, and Bausch + Lomb products. The Salix segment provides gastroenterology products. The Ortho Dermatologics segment offers dermatological products and Solta medical aesthetic devices. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products.
HQLaval, CA
Employee Ratings3.3

Latest Updates

Employees (est.) (Dec 2019)21,700(+3%)
Job Openings195
Revenue (FY, 2020)$8 B(-6%)
Share Price (May 2022)C$14(+3%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Bausch Health

Joseph C. Papa

Joseph C. Papa

Chairman of the Board, Chief Executive Officer
Louis Yu

Louis Yu

Chief Quality Officer
Paul S. Herendeen

Paul S. Herendeen

Executive Vice President and Chief Financial Officer
Tage Ramakrishna

Tage Ramakrishna

Chief Medical Officer, President, R&D
Joseph Gordon

Joseph Gordon

President & Co-Head, Bausch + Lomb/International
Scott Hirsch

Scott Hirsch

Senior Vice President, Chief Strategy Officer
Show more

Bausch Health Office Locations

Bausch Health has offices in Laval, Steinbach, Vaughan, Bridgewater Township and in 43 other locations
Laval, CA (HQ)
2150 Boulevard Saint-Elzéar O
Steinbach, CA
100 Life Sciences Pkwy
Vaughan, CA
520 Applewood Crescent, Concord
Buenos Aires, AR
Av. del Libertador 174
Wien, AT
Office Park I, Top B02
Sarajevo, BA
Tower A, Fra Anđela Zvizdovića 1
Show all (50)

Bausch Health Financials and Metrics

Bausch Health Revenue

Bausch Health's revenue was reported to be $8.03 b in FY, 2020

Revenue (Q1, 2021)


Net income (Q1, 2021)


EBIT (Q1, 2021)


Market capitalization (13-May-2022)


Closing stock price (13-May-2022)


Cash (31-Mar-2021)



Bausch Health's current market capitalization is C$5 b.
USDFY, 2017FY, 2018FY, 2019FY, 2020



Revenue growth, %


Cost of goods sold


Gross profit

USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021



Cost of goods sold


Gross profit


Gross profit Margin, %

USDFY, 2017FY, 2018FY, 2019



Accounts Receivable


Prepaid Expenses



USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income


Depreciation and Amortization




Accounts Payable

USDFY, 2017




4.3 x


0.7 x

Financial Leverage

6.3 x

P/E Ratio

Show all financial metrics

Bausch Health Operating Metrics

FY, 2017FY, 2018FY, 2019Feb, 2021


1.6 k1.5 k1.4 k

Product Brands


Manufacturing Facilities



Show all operating metrics

Bausch Health Acquisitions / Subsidiaries

Company NameDateDeal Size
Synergetics USASeptember 02, 2015
Sprout PharmaceuticalsAugust 20, 2015$1 b
Amoun PharmaceuticalJuly 17, 2015$800 m
Salix PharmaceuticalsFebruary 22, 2015
DendreonFebruary 20, 2015$495 m
Valeo MedicalAugust 25, 2014
PreCision DermatologyFebruary 03, 2014
Solta MedicalDecember 16, 2013
Bausch & LombMay 28, 2013$8.7 b
Obagi Medical ProductsMarch 20, 2013$344 m
Show more

Bausch Health Revenue Breakdown

Embed Graph

Bausch Health revenue breakdown by business segment: 23.3% from Salix, 54.6% from Bausch + Lomb/International, 6.5% from Ortho Dermatologics, 14.7% from Diversified Products and 1.0% from Other

Bausch Health revenue breakdown by geographic segment: 60.6% from U.S. and Puerto Rico and 39.4% from Other

Human Capital Metrics

Embed Graph
Show all human capital metrics

Bausch Health Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Bausch Health Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset


out of 100

CSRHub logo

Bausch Health Online and Social Media Presence

Embed Graph

Bausch Health News and Updates

Bausch Health Companies Inc. Announces First-Quarter 2022 Results

First-Quarter 2022 Financial Results Revenues of $1.918 Billion GAAP Net Loss of $69 Million Adjusted EBITDA (non-GAAP)1 of $732 Million Bausch + Lomb Commences Trading Under "BLCO" Ticker Following IPO2 Updates Full-Year Revenue and Adjusted EBITDA (non-GAAP)1 Guidance Ranges LAVAL, QC,...

Bausch Health Announces Thomas J. Appio As Chief Executive Officer

LAVAL, QC, May 6, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) (Bausch Health) today announced its full leadership team and Board of Directors, including Chief Executive Officer (CEO) Thomas J. Appio.1 Upon completion of the initial public offering (IPO) of the Bausch...

Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10

LAVAL, QC, April 29, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its first-quarter financial results on Tuesday, May 10, 2022. Bausch Health will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and...

Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation

LAVAL, QC and VAUGHAN, ON, April 28, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that, in connection with its previously announced intention to separate its eye health business, it has entered into an arrangement...

Global Acne Treatment Market Report 2022-2025 Featuring Key Players - Vyne Therapeutics, Bausch Health, Nestle, & Abbvie

Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Global Acne Treatment Market: Analysis By Acne Type (Inflammatory and Non- Inflammatory), By Treatment Type (Medication and Therapeutic Devices), Size & Trends with Impact of Covid-19 and Forecast up to 2025" report has been added to ResearchAndM…

Bausch Health Will Reduce Debt By $200 Million

LAVAL, QC, March 29, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $200 million through the pay down of its senior secured term loans on March 31, 2022, using cash generated from operations....
Show more

Bausch Health Frequently Asked Questions

  • When was Bausch Health founded?

    Bausch Health was founded in 1959.

  • Who are Bausch Health key executives?

    Bausch Health's key executives are Joseph C. Papa, Louis Yu and Paul S. Herendeen.

  • How many employees does Bausch Health have?

    Bausch Health has 21,700 employees.

  • What is Bausch Health revenue?

    Latest Bausch Health annual revenue is $8 b.

  • What is Bausch Health revenue per employee?

    Latest Bausch Health revenue per employee is $369.9 k.

  • Who are Bausch Health competitors?

    Competitors of Bausch Health include Pfizer, Merck and Novartis.

  • Where is Bausch Health headquarters?

    Bausch Health headquarters is located at 2150 Boulevard Saint-Elzéar O, Laval.

  • Where are Bausch Health offices?

    Bausch Health has offices in Laval, Steinbach, Vaughan, Bridgewater Township and in 43 other locations.

  • How many offices does Bausch Health have?

    Bausch Health has 50 offices.